A nomogram is progressively being used as a useful predictive tool for cancer prognosis. A nomogram to predict survival in nonresectable pancreatic cancer treated with chemotherapy has not been ...

Decades from now, when we fully understand the biologic basis for the clinical heterogeneity of prostate cancer, we will think of the current era as the Golden Age of Prostate Nomograms. Driven by the ...

Background: The predictive probability of breast cancer nomograms for non–sentinel node metastases (NSLNM) after neoadjuvant chemotherapy (NCT) in patients with a positive sentinel lymph node (SLN) ...

Researchers recently developed and validated a nomogram that can predict 2-year and 5-year overall survival (OS) and progression-free survival (PFS) for patients with local-regionally advanced ...

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04 ...

A nomogram model that included log odd of positive lymph node was effective in predicting prognosis of early-onset colorectal cancer (EOCRC). CRC is the third most common cancer in the world and ...

More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs inside the mouth and throat. For patients who undergo surgery to treat this cancer, guidelines ...

Ductal carcinoma in situ (DCIS) is a heterogeneous disease with multiple treatment options including breast-conserving surgery, the option of addition of radiation, and adjuvant endocrine therapy.

Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive measures for various diseases.

Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia. The nomograms predicted overall and ...

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...